NorthWest Biotherapeutics Inc (NWBO)

[QL300]

There is a flaw in that argument. You are assuming 100% of the diluted shares are going to LP which we know are not. Also, that assumes that all shares received by Advent are all profit. Advent has overhead.  From my recollection, Advent is being paid cost plus 15%. This theory doesn't make much sense.